News
The U.K. biopharmaceutical giant’s plans include a proposal for a new drug substance manufacturing center focused on weight-loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback